SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients

Clinical trial NCT04673383 · COMPLETED

Trial details

NCT number: NCT04673383
Sponsor: Small Pharma Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2021-02-04
Primary completion: 2022-10-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.